Presentation to Jefferies Virtual Healthcare Conference
Telix Pharmaceuticals Limited has today announced that Group CBO Dr. David Cade presented at Jefferies Virtual Healthcare...
Read moreLatest News
Category: Events
Telix presents IPAX-1 study in glioblastoma treatment at ASCO 2020
Telix Pharmaceuticals is pleased to announce that the IPAX-1 study will be presented at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program to be held May 29...
Read more
Telix Supports Molecular Imaging Summer Program at MSKCC
Telix Pharmaceuticals Ltd is pleased to announce our support of the Molecular Imaging Summer Program at...
Read more
Webcast of CEO’s presentation to Jefferies 2019 London Healthcare Conference
Telix Pharmaceuticals Limited is pleased to announce that Group CEO, Dr. Christian Behrenbruch, presented at Jefferies 2019 London Healthcare Conference....
Read more
Dr. Christian Behrenbruch, CEO of Telix Pharmaceuticals Limited, to speak at Jefferies 2019 London Healthcare Conference
Dr. Christian Behrenbruch, CEO of Telix Pharmaceuticals Limited will speak at Jefferies 2019 London Healthcare Conference. This year marks the 10th anniversary of now the largest healthcare-dedicated conference in Europe,...
Read more
Telix Pharmaceuticals to Present at Jefferies Healthcare Conference
Telix Pharmaceuticals is pleased to announce Telix’s CEO, Dr. Christian Behrenbruch will present at the Jefferies Healthcare Conference at the Grand Hyatt Hotel in New York at 8:00 AM EDT...
Read more